Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06698497 · ClinicalTrials.gov registry record · NA
Boosting COVID-19 Vaccination Uptake Using Wastewater Surveillance
A NA study, sponsored by Syracuse University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT06698497 is a NA study that has completed, run by Syracuse University. The registered enrollment target is 40 participants.
The verdict
NCT06698497, a NA study, has completed, sponsored by Syracuse University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Vaccinations are among the most successful and critical public health interventions. Despite the enormous protection that vaccines provide to public health, both delays and refusals of vaccines (vaccine hesitancy) are on the rise. Given that low vaccination rates present both an individual and community risk, it is critical that measures are taken to increase vaccination uptake in both rural and urban counties in New York. Wastewater surveillance of SARS-CoV-2 has been shown to be a leading indicator of pending surges. This study will examine whether a communications campaign based upon SARS-CoV-2 wastewater surveillance data can increase COVID-19 vaccine uptake. Forty counties have been selected for the communication campaign (20 in the treatment group and 20 in the control group). A difference-in-differences method will be applied to assess the impact of the communications campaign on vaccine uptake, which observes the outcomes between a control and treatment group over pre- and post-intervention time periods. The communications campaign will be evaluated using the change in vaccination status of residents of the treatment and control counties. Outcomes will also be compared between demographic groups including race and ethnicity because of differences in vaccination rates that have been already observed. We hypothesize that information regarding COVID-19 provided by wastewater surveillance that is geographically based and more local to communities will increase COVID-19 vaccine uptake. This theory of local information having an impact on health behavior is a novel application of the health belief model to increase vaccine uptake.
Interventions
- BEHAVIORAL Communication Campaign
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-09-13 |
| Est. Completion | 2025-07-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06698497
The ClinicalTrials.gov registry entry for NCT06698497 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syracuse University, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Communication Campaign is the first listed.
NCT06698497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06698497 about?
NCT06698497 is a clinical study titled "Boosting COVID-19 Vaccination Uptake Using Wastewater Surveillance". Vaccinations are among the most successful and critical public health interventions. Despite the enormous protection that vaccines provide to public health, both delays and refusals of vaccines (vaccine hesitancy) are on the rise. Given that low vaccination rates present both an individual and commu...
What is the current status of trial NCT06698497?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2024-09-13. Estimated completion is 2025-07-10.
What interventions are being tested in trial NCT06698497?
The interventions under investigation include: Communication Campaign (BEHAVIORAL).
Who is sponsoring clinical trial NCT06698497?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.